首页> 外国专利> Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines

Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines

机译:百日咳毒素突变体,能够产生这种突变体的球藻菌株及其在开发百日咳疫苗中的用途

摘要

New pertussis toxin (PT) mutants are described being immunologically active and having reduced or no toxicity, characterized in that at least one of the aminoacid residues Glu129, Asp11, Trp26, Arg9, Phe50, Asp1, Arg13, Tyr130, Gly86, Ile88, Tyr89, Tyr8, Gly 44, Thr53 and Gly80 or subunit's 1 aminoacid sequence is deleted and substituted by a different aminoacid residue selected in the group of natural aminoacids; Bordetella strains capable of providing and secreting said PT mutants and means and methods for obtaining them are also described.;The Bordetella strains and the PT mutants produced by them are particularly suitable for the preparation of effective cellular and acellular antipertussis vaccines.;(FIG. 1)
机译:描述了新的百日咳毒素(PT)突变体具有免疫活性并具有降低的毒性或无毒性,其特征在于氨基酸残基Glu129,Asp11,Trp26,Arg9,Phe50,Asp1,Arg13,Tyr130,Gly86,Ile88,Tyr89中的至少一个,删除Tyr8,Gly 44,Thr53和Gly80或亚基的1个氨基酸序列,并用选自天然氨基酸组的不同氨基酸残基取代;还描述了能够提供和分泌所述PT突变体的Bordetella菌株及其获得方法和方法。; Bordetella菌株和由其产生的PT突变体特别适合于制备有效的细胞和无细胞百日咳疫苗。 >图1

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号